Printer Friendly

COMPANY INFORMATION
Medicago Inc. 600-1020 rte de l'Eglise Québec, QC G1V 3V9 Tel: (418) 658-9393 Fax: (418) 658-6699 Contact Name Arianna Vanin Industry Biotechnology		Key Executives Andrew J. Sheldon, CEO Pierre Labbé, CFO Develops and commercializes vaccines based on proprietary virus-like particles (VLPs) and manufacturing technologies.
FP ADVISOR COVERAGE Medicago Inc. • FP Corporate Surveys • FP Directory of Directors • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 5/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/MDG $0.49 $0.86 $0.15 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 276,672 n.a. $-0.11 Sept. 30/09 127.91% -14.36% n.a. $55,776
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 2,444 74 156 Net income (7,649) (6,273) (7,758) Total assets 20,604 6,662 9,551 $ $ $ Earnings per share* (0.17) (0.32) (0.68)   * Common

COMPANY NEWS

Results for 'Medicago Inc.' from past 30 days: No hits. (Links are to articles.)